Frequency, site, and type of malignancies in our PsA cohort taking biological therapy.
| No. Patients Taking Various Anti-TNF Agents | No. Patients Showing Malignancies (%) | Site and Type of Malignancies (no. patients) |
|---|---|---|
| 126; ETN | 6 (2) | Lung carcinoma (2); ovarian teratoma (1); breast cancer (1); bladder carcinoma (1); squamous cell skin carcinoma (1) |
| 116; ADA | 4 (1.3) | Basal cell carcinomas (2); squamous cell carcinoma of the tongue (1); breast cancer (1) |
| 35; IFX | 4 (1.3) | Renal carcinoma (1); papillar carcinoma of the thyroid (1); meningioma (1); Kaposi sarcoma (1) |
| 19; GOL | — | — |
PsA: psoriatic arthritis; TNF: tumor necrosis factor; ADA: adalimumab; ETN: etanercept; GOL: golimumab; IFX: infliximab.